2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
13
Neoplasms
12
Brain Neoplasms
6
Prostatic Neoplasms
5
Neoplasm Metastasis
4
Lung Neoplasms
4
Sarcoma
3
Multiple Myeloma
3
Melanoma
3
Glioblastoma
3
Gastrointestinal Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Synovial
2
Rectal Neoplasms
2
Pain
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neuroendocrine Tumors
2
Nasopharyngeal Carcinoma
2
Mesothelioma
2
Liposarcoma
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Glioma
2
Fatigue
2
Colorectal Neoplasms
2
Interventions
Rituximab
99
Cyclophosphamide
63
fludarabine phosphate
55
Peripheral Blood Stem Cell Transplantation
52
Mycophenolic Acid
34
Whole-Body Irradiation
33
Bortezomib
33
ibrutinib
29
Dexamethasone
27
Tacrolimus
26
Cyclosporine
25
Busulfan
23
Etoposide
22
Melphalan
20
Filgrastim
20
zanubrutinib
18
Methotrexate
18
Lenalidomide
18
Antilymphocyte Serum
18
Radiotherapy
16
Bendamustine Hydrochloride
14
Sirolimus
13
Calcium Dobesilate
11
Flow Cytometry
10
Everolimus
10
venetoclax
9
ibritumomab tiuxetan
9
Prednisone
9
Indium
9
Cyclosporins
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Quality of Life
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled